<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR33">
 <label>33.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ost</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Reynders</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Decaestecker</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Fonteyne</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Lumen</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>De Bruycker</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence</article-title>
  <source>A Prospective, Randomized, Multicenter Phase II Trial. J Clin Oncol Off J Am Soc Clin Oncol</source>
  <year>2018</year>
  <volume>36</volume>
  <issue>5</issue>
  <fpage>446</fpage>
  <lpage>453</lpage>
  <pub-id pub-id-type="doi">10.1200/JCO.2017.75.4853</pub-id>
 </element-citation>
</ref>
